Unknown NA INTERVENTIONAL 1-arm NCT02210624

Safety and Efficacy Assessment of Autologous Bone-marrow Derived Adult Mesenchymal Stem Cell Therapy in Patients With Anoxic(or Hypoxic) Brain Injury Pilot Trial

An Open-label, Safety and Efficacy Assessment of Autologous Bone-marrow Derived Mesenchymal Stem Cell Therapy in Anoxic (or Hypoxic) Brain Injury.

Sponsor: Hyun Young Kim

Conditions Anoxic Brain Injury

Interventions HYNR-CS inj.

Updated 8 times since 2017 Last updated: Aug 8, 2017 Started: Mar 31, 2013 Primary completion: Dec 31, 2018 Completion: Dec 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02210624, this NA trial focuses on Anoxic Brain Injury and remains ongoing. Sponsored by Hyun Young Kim, it has been updated 8 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Unknown NA
Sep 2024 — Sep 2025 [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Sep 2019 — Jan 2021 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status

▶ Show 3 earlier versions

Jun 2018 — Sep 2019 [monthly]

Recruiting NA
Aug 2017 — Jun 2018 [monthly]

Recruiting NA

Status: Unknown Status → Recruiting
Jan 2017 — Aug 2017 [monthly]

Unknown Status NA

First recorded

Mar 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hyun Young Kim

Data source: Hanyang University Seoul Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seoul, South Korea